A biotechnology company, Novavax, is engaged in developing innovative vaccines to prevent serious infectious diseases.

Source: https://247wallst.com/investing/2023/08/04/4-biotech-stocks-set-to-outpace-q2-earnings-estimates/

Acadian Asset Management LLC now owns 431 shares of the biotechnology company’s stock valued at $32,000 after acquiring an additional 344 shares during the period.

Source: https://www.americanbankingnews.com/2023/06/02/british-columbia-investment-management-corp-sells-1876-shares-of-biomarin-pharmaceutical-inc-nasdaqbmrn.html

Acadian Asset Management LLC now owns 431 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 344 shares in the last quarter.

Source: https://www.etfdailynews.com/2023/03/23/baystate-wealth-management-llc-buys-new-shares-in-biomarin-pharmaceutical-inc-nasdaqbmrn/

Additional focus was on recent developments in biotechnology and its possible consequences for the development of new types of biological weapons."

Source: https://www.memri.org/reports/irans-illicit-procurement-related-weapons-mass-destruction-netherlands-sweden-and-germany

Alliancebernstein L.P. now owns 1,079,105 shares of the biotechnology company’s stock worth $182,703,000 after buying an additional 267,436 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/08/14/225-shares-in-repligen-co-nasdaqrgen-acquired-by-clearstead-advisors-llc.html

Although originally intended to warn of the threat of nuclear Armageddon, the Doomsday Clock also takes into account the likelihood of other emerging threats such as climate change and advances in biotechnology and artificial intelligence.

Source: https://www.expressandstar.com/news/uk-news/2023/01/24/doomsday-clock-moves-to-90-seconds-to-midnight--the-closest-in-history/

American International Group Inc. now owns 39,212 shares of the biotechnology company’s stock worth $284,000 after buying an additional 2,067 shares during the period.

Source: https://www.americanbankingnews.com/2023/09/07/exoduspoint-capital-management-lp-boosts-stock-position-in-coherus-biosciences-inc-nasdaqchrs.html

Andy Hover has joined ourHRpeople after working in human resources for nearly 30 years within the biotechnology and chemical sectors, providing commercially astute HR advice and support in the UK and abroad.

Source: https://www.business-live.co.uk/professional-services/wiltshire-based-hr-firm-appoints-28161780

Annandale Capital LLC now owns 800,000 shares of the biotechnology company’s stock worth $464,000 after buying an additional 90,000 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/05/01/aptose-biosciences-apto-scheduled-to-post-quarterly-earnings-on-monday.html

AQR Capital Management LLC now owns 2,826 shares of the biotechnology company’s stock worth $366,000 after purchasing an additional 95 shares in the last quarter.

Source: https://www.americanbankingnews.com/2023/08/13/bank-of-new-york-mellon-corp-has-263-91-million-position-in-sarepta-therapeutics-inc-nasdaqsrpt.html

Armistice Capital LLC now owns 5,000,000 shares of the biotechnology company’s stock worth $21,600,000 after buying an additional 4,276,000 shares during the period.

Source: https://www.dailypolitical.com/2023/02/26/aurinia-pharmaceuticals-auph-outperform-rating-reiterated-at-royal-bank-of-canada.html

Arvinas, Inc, a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Source: https://www.etfdailynews.com/2023/08/09/barclays-trims-arvinas-nasdaqarvn-target-price-to-39-00/

A Scottish biotechnology company specialising in anti-viral treatments has flagged its intention to raise further investment ahead of a possible stock market flotation.

Source: https://www.heraldscotland.com/business_hq/23483128.ilc-scottish-drug-group-lays-flotation-strategy/?ref=rss

As the longevity biotechnology landscape continues to expand, it's crucial for stakeholders, from investors to researchers, to have a clear understanding of what truly constitutes a longevity biotechnology company (LBC).

Source: https://www.forbes.com/sites/alexzhavoronkov/2023/09/16/what-is-a-longevity-biotechnology-company/

As the longevity biotechnology landscape continues to expand, it's crucial for stakeholders, from investors to researchers, to have a clear understanding of what truly constitutes a longevity biotechnology company (LBC).

Source: https://www.forbes.com/sites/alexzhavoronkov/2023/09/16/what-is-a-longevity-biotechnology-company/

As the market attempted to recover from a recent series of disappointing performances, biotechnology firm ) represented a dramatic winner.

Source: https://investorplace.com/2023/09/why-is-baudax-bio-bxrx-stock-up-75-today/

At the time he became infected with coronavirus in February 2020, he was working from home for the biotechnology corporation Genentech.

Source: https://www.independent.co.uk/news/world/americas/covid-psychosis-cdc-long-term-effects-vaccine-b2324848.html

Avidity Partners Management LP now owns 3,275,000 shares of the biotechnology company’s stock worth $72,672,000 after buying an additional 675,000 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/08/24/avidity-biosciences-inc-nasdaqrna-stake-raised-by-artisan-partners-limited-partnership.html

Baystate Wealth Management LLC now owns 500 shares of the biotechnology company’s stock worth $42,000 after acquiring an additional 375 shares in the last quarter.

Source: https://www.etfdailynews.com/2023/05/27/bio-techne-co-nasdaqtech-shares-purchased-by-hightower-advisors-llc/

Benitec Biopharma Inc, a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Source: https://www.etfdailynews.com/2023/12/09/benitec-biopharma-nasdaqbntc-stock-crosses-above-50-day-moving-average-of-3-35/